Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus.

  title={Sitagliptin/Metformin (janumet) as combination therapy in the treatment of type-2 diabetes mellitus.},
  author={Erin L St Onge and Shannon A. Miller and Elizabeth Clements},
  journal={P & T : a peer-reviewed journal for formulary management},
  volume={37 12},
Used together, sitagliptin (Januvia) and metformin (Glucophage) help to improve glycemic levels in diabetic patients, suggesting a synergy between the agents. However, the cost of sitagliptin and the need for more data may restrict its use. More studies are needed to assess the effects of long-term sitagliptin and to determine its role in combination therapy. 

From This Paper

Figures, tables, and topics from this paper.


Publications referenced by this paper.
Showing 1-10 of 35 references

Case report of acute necrotizing pancreatitis associated with combination treatment of sitagliptin and exenatide.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists • 2012


FDA. Acto
Available at: MedWatch/SafetyInformation/SafetyAlertsforHumanMedical Products/ucm150451.htm?utm. Accessed June 5, • 2012

Communication: Information for healthcare professionals: Acute pancreatitis and sitagliptin (marketed as Januvia and Janumet)

FDA Drug Safet
Available at: PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm183764. htm. Accessed October 20, • 2011

Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes

A Perez-Montverde, T Seck, L Xu
Int J Clin Pract • 2011

Similar Papers

Loading similar papers…